BASG Notice on Drug-Device Combination Products
The article provides a general overview of the regulatory framework for combination products applicable in the EU in general and in Austria specifically.
The article provides a general overview of the regulatory framework for combination products applicable in the EU in general and in Austria specifically.
The new article describes in detail the relevant harmonised standards applicable to medical devices, and also the way they should be applied.
The new article describes in detail the approach to be applied when it comes to the re-assessment of designation under the new regulatory framework.
The new article highlights certain specific aspects associated with designation, such as notification procedure or changes to the scope of designation.
The new article clarifies the aspects associated with the designation decision to be taken with respect to the applicant entity in the context of the CAB/NB designation process.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report